In a more recent study HSP70 inhibitors, VER-155008 and MAL3-101 were tested either alone or concurrently with the HSP90 inhibitor, STA-9090, for their ability to reduce viability of muscle invasive bladder cancer cells. This evidence concerns the gene HSPA1A and urinary bladder carcinoma.